Page last updated: 2024-08-16

ribavirin and Drug Abuse, Intravenous

ribavirin has been researched along with Drug Abuse, Intravenous in 104 studies

Research

Studies (104)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (1.92)	18.2507
2000's	50 (48.08)	29.6817
2010's	51 (49.04)	24.3611
2020's	1 (0.96)	2.80

Authors

Authors	Studies
Farley, J; Farley, TA; Fischer, B; Haydon, E; Rehm, J; Vasdev, S	1
Amin, J; Applegate, TL; Backmund, M; Bourgeois, S; Bruggmann, P; Bruneau, J; Conway, B; Cunningham, EB; Dalgard, O; Dore, GJ; Dunlop, A; Foster, GR; Grebely, J; Hajarizadeh, B; Hellard, M; Marks, PS; Midgard, H; Quiene, S; Robaeys, G; Shaw, D; Staehelin, C; Swan, T; Weltman, M	1
Amin, J; Backmund, M; Bourgeois, S; Bruggmann, P; Bruneau, J; Conway, B; Cunningham, EB; Dalgard, O; Dore, GJ; Dunlop, A; Foster, GR; Grebely, J; Hajarizadeh, B; Hellard, M; Marks, PS; Midgard, H; Quiene, S; Robaeys, G; Thurnheer, MC; Weltman, M	1
Dillon, JF; Radley, A; Tait, J	1
Altice, FL; Barnard, T; Filippovych, S; Mazhnaya, A; Meteliuk, A; Zelenev, A	1
Bergmann, OM; Björnsson, ES; Fridriksdottir, RH; Gottfredsson, M; Gudnason, T; Hansdottir, I; Heimisdottir, M; Hellard, M; Johannsson, B; Löve, A; Löve, TJ; Olafsson, S; Runarsdottir, V; Sigurdardottir, B; Tyrfingsson, T	1
Avril, E; Bouscaillou, J; Butsashvili, M; Etienne, A; Gamezardashvili, A; Inaridze, I; Kamkamidze, G; Kharshiladze, D; Kikvidze, T; Labartkava, K; Le Pluart, D; Luhmann, N	1
Applegate, TL; Bruggmann, P; Bruneau, J; Castro, E; Conway, B; Cooper, C; Crawford, S; Cunningham, EB; Dalgard, O; Daulouede, JP; Dore, GJ; Dunlop, A; Erratt, A; Feld, JJ; Fraser, C; Gane, E; Grebely, J; Hajarizadeh, B; Hellard, M; Kronborg, I; Lacombe, K; Marks, P; Matthews, GV; Moriggia, A; Petoumenos, K; Powis, J; Schmid, P; Shaw, D; Stedman, C	1
Chan, HL; Cheung, D; Chim, AM; Chung, C; Fung, JY; Hui, YT; Loo, CK; Wong, GL; Wong, VW	1
Amin, J; Artenie, AA; Bruggmann, P; Bruneau, J; Conway, B; Cooper, C; Cunningham, EB; Dalgard, O; Dore, GJ; Erratt, A; Feld, JJ; Grebely, J; Hajarizadeh, B; Hellard, M; Lacombe, K; Litwin, AH; Marks, P; Matthews, GV; Powis, J; Quiene, S; Read, P; Stedman, C	1
Hickman, M; Martin, NK; Miners, A; Vickerman, P	1
Bojovic, K; Delic, D; Jevtovic, DJ; Katanic, N; Milosevic, I; Pesic, I; Simonovic, J; Svirtlih, N	1
Conway, B; Grebely, J; Hilsden, RJ; Lee, SS; Macphail, G	1
Backmund, M; Gansefort, D; Gerken, G; Gölz, J; Reimer, J; Scherbaum, N; Schmidt, CS; Schulte, B; Verthein, U	1
Fabri, M; Kiralj, K; Mikić, SS; Preveden, T; Ruzić, M; Vukadinov, T	1
Benini, F; Cinquegrana, A; Fasoli, M; Furba, P; Giacò, E; Lanzini, A; Pigozzi, MG; Zanini, B	1
Djordjević, J; Kostić, V; Radović, J; Vujić, S	1
Burki, T	1
Bezemer, G; de Knegt, RJ; Hansen, BE; Hotho, DM; Janssen, HL; Van Gool, AR; Veldt, BJ	1
Arain, A; Bastens, B; Bourgeois, S; Bruckers, L; Buntinx, F; d'Heygere, F; de Galocsy, C; Deltenre, P; Francque, S; George, C; Henrion, J; Janssens, F; Laleman, W; Mathei, C; Moreno, C; Nevens, F; Robaeys, G; Van Overbeke, L; Van Vlierberghe, H; Verrando, R	1
Cockerham-Colas, L; Heo, M; Litwin, AH; Reynoso, S; Roose, RJ; Soloway, IJ; Tenore, C	1
Alavi, M; Balcomb, AC; Bath, N; Day, CA; Dore, GJ; Dunlop, AJ; Grebely, J; Haber, PS; Micallef, M; Phung, N; Treloar, C; Weltman, MD	1
Aabakken, L; Dalgard, O; Grimstad, T; Isaksen, K; Karlsen, L; Sandvei, PK	1
Bellefquih, AM; Benani, A; Essalhi, M; Fayssel, N; Khyatti, M; Serghini, FZ; Trimbitas, RD; Wakrim, L	1
Alavi, M; Dore, GJ; Doyle, JS; Grebely, J; Hellard, ME; Matthews, GV; Spelman, T; Thompson, AJ	1
Axten, D; Dalton, J; Foster, GR; Gardner, H; Kunkel, J; Lewis, H; Tippett, A; Wilkinson, M; Wynne, S	1
Bramness, JG; Dalgard, O; Haukeland, JW; Midgard, H; Skurtveit, S	1
Bruggmann, P; Dober, S; Falcato, L; Helbling, B; Keiser, O; Meili, D; Negro, F	1
Conway, B; deVlaming, S; Duncan, F; Grebely, J; Viljoen, M	1
Bodenheimer, HC; Bonkovsky, HL; Monto, A; Rossi, SJ; Sulkowski, MS; Tice, AD; Yapp, RG	1
Bacosi, D; Baldelli, F; Belfiori, B; Chiodera, A; Ciliegi, P; Francisci, D; Tosti, A	1
Arnsten, JH; Gourevitch, MN; Harris, KA; Kaswan, D; Litwin, AH; Nahvi, S; Soloway, IJ; Tenore, PL; Zamor, PJ	1
Liebman, HA	1
Kreek, MJ; Piccolo, P; Talal, AH	1
Danis, D; Fejdiova, K; Gazdik, F; Gazdikova, K; Kajaba, I; Kratky, A; Laktis, K; Okruhlica, L; Pijak, MR; Wsolova, L	1
Alvarez-Uria, G; Day, JN; Nasir, AJ; Russell, SK; Vilar, FJ	1
Gold, J; Hellard, M; Sacks-Davis, R	1
Mauss, S; Schaefer, M	1
Gallefoss, F; Kristensen, Ø; Opsal, A; Rysstad, O; Skeie, K; Sundøy, A; Vederhus, JK; Øye, I	1
Anagnostou, O; Dimitroulopoulos, D; Manolakopoulos, S; Paraskevas, E; Petroulaki, E; Tsaklakidou, D; Tsamakidis, K; Tzourmakliotis, D; Xinopoulos, D	1
Jovanović, M; Konstantinović, L; Kostić, V; Popović, L; Vrbić, M	1
Brack, J; Deibler, P; Dilg, C; Haasen, C; Isernhagen, K; Reimer, J; Schulte, B; Schütt, S; Verthein, U	1
Ackermann, G; Waizmann, M	1
Barreiro, P; Jiménez-Nacher, I; Labarga, P; Madejón, A; Martín-Carbonero, L; Medrano, J; Resino, S; Rodriguez-Novoa, S; Soriano, V; Tuma, P; Vispo, E	1
Aydin, I; Ferenci, P; Hofer, H; Mueller, C; Neumueller-Guber, S; Scherzer, TM; Staufer, K; Steindl-Munda, P; Wrba, F	1
Bate, JP; Colman, AJ; Frost, PJ; Harley, HA; Shaw, DR	1
Conway, B; Dore, GJ; Duncan, F; Gallagher, L; Genoway, KA; Grebely, J; Knight, E; Krajden, M; Ngai, T; Raffa, JD; Storms, M	1
Hickman, M; Martin, N; Vickerman, P	1
Anagnostou, O; Archimandritis, AJ; Deutsch, MJ; Georgiou, E; Karatapanis, S; Manesis, E; Manolakopoulos, S; Papatheodoridis, GV; Tiniakou, E; Tzourmakliotis, D	1
Alavi, M; Dore, GJ; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Shaw, D; van Beek, I; Yeung, B	1
Barton, D; Dore, G; Kronborg, I; Sasadeusz, JJ; Weltman, M; Yoshihara, M	1
Blanco, JL; Calvo, M; González, A; Laguno, M; Larrousse, M; Loncà, M; Mallolas, J; Martínez, E; Martínez-Rebollar, M; Muñoz, A	1
Abbacchi, A; Adewuyi, SA; Debold, C; Hong, BA; Lisker-Melman, M; North, CS; Pollio, DE	1
Carrieri, MP; Dabis, F; Fugon, L; Lacombe, K; Roux, P; Salmon-Céron, D; Sogni, P; Spire, B; Winnock, M	1
Bergin, C; Dillon, A; Farrell, G; Jackson, A; Kieran, J; Mulcahy, F; Norris, S	1
Bull, RA; Dore, GJ; Grebely, J; Hellard, M; Kaldor, J; Lloyd, A; Matthews, GV; Petoumenos, K; Pham, ST; Rawlinson, W; White, PA; Yeung, B	1
Hopwood, M; Newland, J; Rance, J; Treloar, C	1
Alavi, M; Day, C; Dore, GJ; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Van Beek, I; Yeung, B	1
Bárcena, R; Cañete, N; García-Samaniego, J; Gutiérrez, ML; Manzano, ML; Morano, L; Pérez-Álvarez, R; Pérez-López, R; Planas, R; Rodrigo, L; Solá, R	1
Daniš, D; Gazdík, F; Gazdíková, K; Hučková, D; Kajaba, I; Okruhlica, L	1
Burnett, D; Cornett, DD; Lindstrom, MJ; Lucey, MR; Rice, JP; Sawyer, J; Striker, R; Tsotsis, H; Voermans, P	1
Naggie, S; Sulkowski, MS	1
McCaughan, GW	1
Gold, J; Hellard, ME; Hickman, M; Higgs, P; Jenkinson, R; Martin, NK; Sacks-Davis, R; Stoové, MA; Vickerman, P	1
John-Baptiste, A; Krahn, M; Leung, V; van der Velde, G; Yeung, MW	1
Doyle, JS; Hellard, ME; Shiell, AM; Visconti, AJ; Weir, A	1
Des Jarlais, DC; Dimova, RB; Hagan, H; Jacobson, IM; Talal, AH; Zeremski, M	1
Lucidarme, D	1
Allen, S; Berzin, T; Feller, E; Rich, J; Taylor, L	1
García-Samaniego, J; González-Lahoz, J; Núñez, M; Pérez-Olmeda, M; Ríos, P; Soriano, V	1
Bailly, F; Chevallier, M; Chevallier, P; Rocca, P; Trépo, C; Zoulim, F	1
Bevilacqua, P; Bozzola, L; Brown, D; de Lalla, F; Dusheiko, G; Fabris, P; Giordani, MT; Tositti, G; Webster, GJ	1
Lehmann, M; Manns, MP; Meyer, MF; Monazahian, M; Tillmann, HL; Wedemeyer, H	1
González-Lahoz, J; Soriano, V	1
Bertisch, B; Huber, M; Meili, D; Oppliger, R; Renner, EL; Schmid, P; Schönbucher, P; Vernazza, P; Weber, R	1
Alexander, GJ; Hoare, M; Woodall, T	1
Taylor, LE	1
Berg, T; Frey, UH; Gerken, G; Mueller, T; Roggendorf, M; Sarrazin, C; Siffert, W; Weich, V; Zeuzem, S	1
Barreiro, P; Garcia-Samaniego, J; Gonzalez-Lahoz, J; Maida, I; Nunez, M; Ramos, B; Soriano, V	1
Sylvestre, DL	2
Antinori, A; Carioti, J; Caroleo, B; Guadagnino, V; Trotta, MP	1
Bruckers, L; Buntinx, F; Matheï, C; Robaeys, G; Van Ranst, M; Van Vlierberghe, H	1
de los Santos Gil, I; González Cerrajero, M; Pazos García, A; Sanz Sanz, J	1
Fireman, M; Hauser, P; Matthews, AM; Sobel, M; Zucker, B	1
Gorman, JM; Weiss, JJ	1
Agho, K; Byrne, A; Dore, GJ; Hallinan, R	1
Boix-Martínez, V; Clemente-Ricote, G; Marco-Mouriño, A; Núñez-Martínez, O; Portilla-Sogorb, J; Reus-Bañuls, S; Saiz de la Hoya-Zamácola, P; Teixidó i Pérez, N	1
Deibler, P; Haasen, C; Reimer, J	1
Dore, GJ	1
Bull, J; Chua, F; Galhenage, S; Hulse, G; Jeffrey, GP; MacQuillan, G; O'Neil, G; Young, E	1
Fuchs, M; Ludwig, D; Witthoeft, T	1
Antinori, A; Armignacco, O; Babudieri, S; Carioti, J; Caroleo, B; Guadagnino, V; Maio, G; Monarca, R; Montesano, F; Trotta, MP	1
Bosco, G; de Gennaro, M; Fiorini, I; Luchi, S; Meini, M; Moneta, S; Ricciardi, L; Scasso, A	1
Clements, BJ; Sylvestre, DL	1
Heger, B; Krook, AL; Nygaard, E; Stokka, D	1
Conway, B; DeVlaming, S; Duncan, F; Elliott, D; Genoway, K; Grebely, J; Khara, M; Raffa, JD; Viljoen, M	1
Dore, GJ; Hellard, ME; Kaldor, JM; Nguyen, OK	1
Ammassari, A; Giuliani, M; Lacaita, MG; Lajolo, C; Sartorio, A; Scivetti, M; Tamburrini, E; Tumbarello, M	1
Ebeling, F	1
Hoofnagle, JH; Howell, C; Jeffers, L	1
Agarwal, K; Bassendine, DR; Bassendine, MF; Burt, AD; Craig, W; Gilvarry, E; Hewett, M; Jowett, SL; Smith, BC	1
Backmund, M; Eichenlaub, D; Meyer, K; Von Zielonka, M	1

Reviews

11 review(s) available for ribavirin and Drug Abuse, Intravenous

Article	Year
Current approaches to HCV infection in current and former injection drug users. Journal of addictive diseases, 2008, Volume: 27, Issue:2 Topics: Antiviral Agents; Hepatitis C; Humans; Interferons; Patient Care Team; Recurrence; Ribavirin; Substance Abuse, Intravenous	2008
Hepatitis C treatment for injection drug users: a review of the available evidence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49, Issue:4 Topics: Antiviral Agents; Drug Users; Hepatitis C; Humans; Interferons; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2009
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Current drug abuse reviews, 2008, Volume: 1, Issue:2 Topics: Alcoholism; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Illicit Drugs; Interferon alpha-2; Interferon-alpha; Methadone; Narcotics; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous	2008
[Current status of acute hepatitis C]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:3 Topics: Acute Disease; Antiviral Agents; Asymptomatic Diseases; Comorbidity; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Ribavirin; Risk Factors; RNA, Viral; Sexual Behavior; Spain; Substance Abuse, Intravenous; Viremia	2011
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology, 2012, Volume: 142, Issue:6 Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome	2012
Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review. PharmacoEconomics, 2012, Nov-01, Volume: 30, Issue:11 Topics: Antiviral Agents; Cost-Benefit Analysis; Hepatitis C; Humans; Interferons; Mass Screening; Polyethylene Glycols; Quality-Adjusted Life Years; Ribavirin; Risk Factors; Substance Abuse, Intravenous	2012
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:6 Topics: Adult; Antiviral Agents; Drug Users; Female; Hepatitis C; Humans; Interferons; Male; Medication Adherence; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2013
[Hepatitis C and drug use: epidemiology, screening, natural history and treatment]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Follow-Up Studies; France; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferons; Prevalence; Prisons; Prognosis; Prospective Studies; Recurrence; Ribavirin; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders; Time Factors	2002
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV. Current HIV/AIDS reports, 2006, Volume: 3, Issue:4 Topics: Antidepressive Agents; Antiviral Agents; Clinical Trials as Topic; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Mental Disorders; Patient Compliance; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2006
Hepatitis C. Shedding light on the shadow epidemic. Harvard health letter, 1999, Volume: 24, Issue:9 Topics: Hepatitis C; Humans; Interferons; Ribavirin; Substance Abuse, Intravenous; Transfusion Reaction; United States	1999
Hepatitis C in African Americans: summary of a workshop. Gastroenterology, 2000, Volume: 119, Issue:5 Topics: Antiviral Agents; Black or African American; Carcinoma, Hepatocellular; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver Neoplasms; Liver Transplantation; Prevalence; Ribavirin; Substance Abuse, Intravenous; United States; Veterans	2000

Trials

25 trial(s) available for ribavirin and Drug Abuse, Intravenous

Article	Year
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study. The International journal on drug policy, 2017, Volume: 47 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Drug Users; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Self Administration; Substance Abuse, Intravenous; Viral Load	2017
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study. The International journal on drug policy, 2017, Volume: 47 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk-Taking; Secondary Prevention; Substance Abuse, Intravenous; Young Adult	2017
DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy. The International journal on drug policy, 2017, Volume: 47 Topics: Adult; Aged; Analgesics, Opioid; Antiviral Agents; Community Pharmacy Services; Feasibility Studies; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon-alpha; Male; Middle Aged; Opiate Substitution Treatment; Pharmacists; Ribavirin; Substance Abuse, Intravenous; Young Adult	2017
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents. Journal of internal medicine, 2018, Volume: 283, Issue:5 Topics: Antiviral Agents; Benzimidazoles; Carcinoma, Hepatocellular; Drug Therapy, Combination; Fluorenes; Hepatitis C; Humans; Iceland; Incidence; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Needle-Exchange Programs; Population Surveillance; Ribavirin; Sofosbuvir; Substance Abuse, Intravenous; Uridine Monophosphate	2018
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57 Suppl 2 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Viral Load	2013
Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57 Suppl 2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Behavior Therapy; Female; Germany; Hepatitis C; Humans; Interferon-alpha; Male; Medication Adherence; Middle Aged; Opiate Substitution Treatment; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Viral Load; Young Adult	2013
Addicts with chronic hepatitis C: difficult to reach, manage or treat? World journal of gastroenterology, 2013, Nov-28, Volume: 19, Issue:44 Topics: Adult; Antiviral Agents; Cooperative Behavior; Drug Therapy, Combination; Drug Users; Female; Health Services Accessibility; Hepatitis C, Chronic; Humans; Interdisciplinary Communication; Interferon alpha-2; Interferon-alpha; Italy; Male; Medication Adherence; Middle Aged; Patient Care Team; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous; Time Factors; Treatment Outcome	2013
Hepatitis C viral infection among prisoners. Vojnosanitetski pregled, 2013, Volume: 70, Issue:11 Topics: Adult; Age Distribution; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Polyethylene Glycols; Prisoners; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Tattooing; Treatment Outcome	2013
Effects of escitalopram prophylaxis during antiviral treatment for chronic hepatitis C in patients with a history of intravenous drug use and depression. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:10 Topics: Aged; Antiviral Agents; Citalopram; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Placebos; Ribavirin; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2014
Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:11 Topics: Adult; Antiviral Agents; Community Health Nursing; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medication Adherence; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2016
Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration. The American journal of gastroenterology, 2008, Volume: 103, Issue:11 Topics: Adult; Antiviral Agents; Directly Observed Therapy; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Self Administration; Substance Abuse, Intravenous; Treatment Outcome	2008
High virologic sustained response for former young intravenous drug users with chronic hepatitis C treated by pegylated interferon-alpha plus ribavirin. Bratislavske lekarske listy, 2009, Volume: 110, Issue:2 Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Young Adult	2009
Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance. European journal of gastroenterology & hepatology, 2009, Volume: 21, Issue:12 Topics: Adult; Antidepressive Agents; Antiviral Agents; Drug Therapy, Combination; Drug Utilization; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Opiate Substitution Treatment; Patient Compliance; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2009
Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug and alcohol dependence, 2010, Jun-01, Volume: 109, Issue:1-3 Topics: Adult; Antiviral Agents; Female; Genotype; Germany; Health Status; Hepacivirus; Hepatitis C; Heroin; Heroin Dependence; Humans; Interferons; Male; Mental Health; Middle Aged; Narcotics; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Viral Load; Young Adult	2010
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of hepatology, 2011, Volume: 55, Issue:1 Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2011
Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy. Addiction (Abingdon, England), 2011, Volume: 106, Issue:5 Topics: Adult; Analgesics, Opioid; Antiviral Agents; Australia; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome	2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:5 Topics: Adult; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Drug Users; Employment; Female; Hepatitis C; HIV Seropositivity; Humans; Interferon-alpha; Logistic Models; Male; Mental Health; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Participation; Substance Abuse, Intravenous; Surveys and Questionnaires; Viral Load; Young Adult	2012
Interferon alpha-2a plus ribavirin 1,000/1,200 mg versus interferon alpha-2a plus ribavirin 600 mg for chronic hepatitis C infection in patients on opiate maintenance treatment: an open-label randomized multicenter trial. Infection, 2005, Volume: 33, Issue:1 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2005
Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype. The Journal of infectious diseases, 2005, Oct-01, Volume: 192, Issue:7 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Failure	2005
Approaching treatment for hepatitis C virus infection in substance users. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jul-01, Volume: 41 Suppl 1 Topics: Adolescent; Adult; Disease Management; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2005
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:2 Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Viral Load	2006
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Drug Implants; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Prospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2007
Adherence to hepatitis C treatment in recovering heroin users maintained on methadone. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:9 Topics: Adult; Antiviral Agents; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2007
Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study. European addiction research, 2007, Volume: 13, Issue:4 Topics: Administration, Oral; Adult; Antiviral Agents; Buprenorphine; Comorbidity; Drug Therapy, Combination; Feasibility Studies; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Norway; Opioid-Related Disorders; Patient Compliance; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Support; Substance Abuse, Intravenous	2007
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study. The International journal on drug policy, 2007, Volume: 18, Issue:5 Topics: Adult; Antiviral Agents; Australia; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interviews as Topic; Male; Middle Aged; Patient Care Team; Patient Compliance; Patient Selection; Polyethylene Glycols; Recombinant Proteins; Research Design; Ribavirin; Socioeconomic Factors; Substance Abuse, Intravenous; Time Factors; Treatment Outcome	2007

Other Studies

68 other study(ies) available for ribavirin and Drug Abuse, Intravenous

Article	Year
Feasibility and outcome of HCV treatment in a Canadian federal prison population. American journal of public health, 2005, Volume: 95, Issue:10 Topics: Adult; British Columbia; DNA, Viral; Drug Combinations; Feasibility Studies; Federal Government; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Methadone; Middle Aged; Multivariate Analysis; Narcotics; Prevalence; Prisons; Program Evaluation; Retrospective Studies; Ribavirin; Risk Factors; Substance Abuse, Intravenous; Treatment Outcome	2005
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes. The International journal on drug policy, 2017, Volume: 47 Topics: Adult; Antiviral Agents; Coinfection; Female; Genotype; Health Services; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Program Development; Program Evaluation; Recombinant Proteins; Ribavirin; Risk Factors; Sex Factors; Sofosbuvir; Substance Abuse, Intravenous; Sustained Virologic Response; Treatment Outcome; Ukraine; Young Adult	2017
Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study. The International journal on drug policy, 2018, Volume: 62 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Drug Users; Female; Genotype; Georgia; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin; Sofosbuvir; Substance Abuse, Intravenous	2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. The International journal on drug policy, 2018, Volume: 62 Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Medication Adherence; Middle Aged; Opiate Substitution Treatment; Proline; Qualitative Research; Ribavirin; Ritonavir; RNA, Viral; Substance Abuse, Intravenous; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine	2018
Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:9 Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Drug Users; Female; Hepatitis C Antibodies; Hepatitis C, Chronic; Hong Kong; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Program Evaluation; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous; Sustained Virologic Response; Time Factors; Treatment Outcome	2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International St Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 05-23, Volume: 70, Issue:11 Topics: Analgesics, Opioid; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Male; Middle Aged; Pharmaceutical Preparations; Ribavirin; Substance Abuse, Intravenous; Sustained Virologic Response	2020
How cost-effective is hepatitis C virus treatment for people who inject drugs? Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2013
The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:6 Topics: Adult; Antiviral Agents; Drug Combinations; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome	2013
Treatment of chronic hepatitis C in injecting drug users--a 5-year follow-up. Vojnosanitetski pregled, 2013, Volume: 70, Issue:8 Topics: Adult; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Recombinant Proteins; Recurrence; Ribavirin; Serbia; Substance Abuse, Intravenous; Treatment Outcome	2013
Elimination on the agenda for hepatitis C. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:6 Topics: Antiviral Agents; Disease Eradication; Global Health; Hepatitis C; Humans; Injections; Interferons; Ribavirin; Sofosbuvir; Substance Abuse, Intravenous; Uridine Monophosphate	2014
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. Journal of medical virology, 2016, Volume: 88, Issue:1 Topics: Adult; Antiviral Agents; Belgium; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Proline; Prospective Studies; Retrospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2016
Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program. The International journal on drug policy, 2015, Volume: 26, Issue:10 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Opiate Substitution Treatment; Polyethylene Glycols; Proline; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2015
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study. Addiction (Abingdon, England), 2016, Volume: 111, Issue:2 Topics: Adult; Aged; Ambulatory Care; Antiviral Agents; Community Health Centers; Delivery of Health Care; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medication Adherence; Middle Aged; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome	2016
Hepatitis C treatment at three Norwegian hospitals 2000-2011. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2015, Dec-01, Volume: 135, Issue:22 Topics: Adult; Age Factors; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Hospitals; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Norway; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Sex Factors; Substance Abuse, Intravenous; Treatment Outcome; Viral Load	2015
Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users. Journal of medical virology, 2016, Volume: 88, Issue:8 Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Disease Reservoirs; Drug Users; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Morocco; Mutation; Phylogeny; Polymerase Chain Reaction; Ribavirin; Sequence Analysis, DNA; Substance Abuse, Intravenous; Viral Core Proteins	2016
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort. PloS one, 2016, Volume: 11, Issue:6 Topics: Adult; Antiviral Agents; Australia; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Needle Sharing; Patient Compliance; Patient Outcome Assessment; Polyethylene Glycols; Prospective Studies; Quality of Life; Ribavirin; Substance Abuse, Intravenous; Surveys and Questionnaires	2016
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PloS one, 2016, Volume: 11, Issue:11 Topics: Adult; Antipsychotic Agents; Antiviral Agents; Benzodiazepines; Buprenorphine, Naloxone Drug Combination; Disease Notification; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Methadone; Middle Aged; Norway; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Registries; Ribavirin; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous	2016
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. Journal of viral hepatitis, 2008, Volume: 15, Issue:10 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Patient Compliance; Ribavirin; Substance Abuse, Intravenous; Switzerland; Treatment Outcome	2008
Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:4 Topics: Adolescent; Adult; Antiviral Agents; Buprenorphine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2009
Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. Journal of substance abuse treatment, 2009, Volume: 37, Issue:1 Topics: Adult; Analgesics, Opioid; Antiviral Agents; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Opioid-Related Disorders; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; United States	2009
Viral-associated immune thrombocytopenic purpura. Hematology. American Society of Hematology. Education Program, 2008 Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Bisexuality; Hemorrhage; Hepacivirus; Hepatitis C; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Ribavirin; Risk Factors; Substance Abuse, Intravenous	2008
Treating chronic hepatitis C in recovering opiate addicts: yes, we can. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:4 Topics: Antiviral Agents; Buprenorphine; Drug Therapy, Combination; Drug Users; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Italy; Methadone; Narcotics; Patient Compliance; Polyethylene Glycols; Practice Guidelines as Topic; Practice Patterns, Physicians'; Recombinant Proteins; Refusal to Treat; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; United States	2009
Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:7 Topics: Adult; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Drug Users; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Odds Ratio; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Failure; Viral Load	2009
[Short-term treatment of Hepatitis C in heroin-dependent patients]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2009, Aug-27, Volume: 129, Issue:16 Topics: Adult; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Heroin Dependence; Humans; Interferon alpha-2; Interferon-alpha; Male; Patient Care Team; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Time Factors; Treatment Outcome	2009
[Efficiency of a combined peginterferon alpha-2a and ribavarin therapy in intravenous opiate substances abusers with chronic hepatitis C]. Vojnosanitetski pregled, 2009, Volume: 66, Issue:10 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Morphine Dependence; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2009
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin. Journal of substance abuse treatment, 2010, Volume: 38, Issue:4 Topics: Adult; Antidepressive Agents; Antiviral Agents; Buprenorphine; Citalopram; Depression; Directly Observed Therapy; Drug Administration Schedule; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2010
Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients. Journal of viral hepatitis, 2011, Volume: 18, Issue:5 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C; HIV Infections; HIV Seropositivity; Humans; Incidence; Interferons; Male; Population Dynamics; Prevalence; Ribavirin; RNA, Viral; Substance Abuse, Intravenous	2011
Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. Journal of viral hepatitis, 2011, Volume: 18, Issue:7 Topics: Adolescent; Adult; Aged; Antiviral Agents; Coinfection; Female; Flaviviridae Infections; GB virus C; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome	2011
High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C. Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:7 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Drug Users; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Prevalence; Prisoners; Recurrence; Retrospective Studies; Ribavirin; RNA, Viral; South Australia; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Viral Load	2010
Reinfection with hepatitis C virus following sustained virological response in injection drug users. Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:7 Topics: Adult; Antiviral Agents; British Columbia; Community Health Centers; Drug Therapy, Combination; Drug Users; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Remission, Spontaneous; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Viral Load	2010
Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere. Drug and alcohol dependence, 2011, Jan-15, Volume: 113, Issue:2-3 Topics: Antiviral Agents; Australia; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Methadone; Models, Statistical; Opiate Substitution Treatment; Polyethylene Glycols; Prevalence; Primary Prevention; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2011
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:10 Topics: Adolescent; Adult; Antiviral Agents; Chi-Square Distribution; Contraindications; Drug Therapy, Combination; Drug Users; Female; Genotype; Greece; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Medication Adherence; Middle Aged; Odds Ratio; Retrospective Studies; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Time Factors; Treatment Outcome; Viral Load; Young Adult	2010
The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: a case report and discussion. Journal of clinical psychology in medical settings, 2011, Volume: 18, Issue:1 Topics: Adaptation, Psychological; Alcoholism; Antiviral Agents; Awareness; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Education as Topic; Problem Solving; Psychotherapy; Psychotherapy, Group; Recombinant Proteins; Recurrence; Ribavirin; Social Support; Substance Abuse, Intravenous; Suicidal Ideation	2011
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users. Addiction (Abingdon, England), 2012, Volume: 107, Issue:1 Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Ethanol; Female; France; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Medication Adherence; Middle Aged; Prospective Studies; Ribavirin; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires	2012
High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic. International journal of STD & AIDS, 2011, Volume: 22, Issue:10 Topics: Adult; Ambulatory Care Facilities; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Program Evaluation; Recombinant Proteins; Referral and Consultation; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2011
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Cohort Studies; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Superinfection; Treatment Outcome	2012
The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Social science & medicine (1982), 2012, Volume: 74, Issue:2 Topics: Ambulatory Care Facilities; Antiviral Agents; Australia; Cross-Sectional Studies; Female; Health Care Surveys; Health Services Accessibility; Hepatitis C; Humans; Interferons; Interviews as Topic; Male; Methadone; Narcotics; Opiate Substitution Treatment; Politics; Prejudice; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous	2012
Acute hepatitis C in Spain: a retrospective study of 131 cases. Revista espanola de enfermedades digestivas, 2012, Volume: 104, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Viral; Antiviral Agents; Cohort Studies; Cross Infection; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunoenzyme Techniques; Immunoglobulin G; Interferon-gamma; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Spain; Substance Abuse, Intravenous; Viral Load; Young Adult	2012
[Virological sustained response to former young intravenous drug abusers with chronic hepatitis C treated by pegylated interferon-α plus ribavirin]. Vnitrni lekarstvi, 2012, Volume: 58, Issue:2 Topics: Adolescent; Adult; Antibodies, Viral; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Immunologic Factors; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Young Adult	2012
Comparison of hepatitis C virus treatment between incarcerated and community patients. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:4 Topics: Adult; Age Factors; Aged; Analysis of Variance; Antiviral Agents; Confidence Intervals; Databases, Factual; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferon-alpha; Logistic Models; Male; Middle Aged; Odds Ratio; Polyethylene Glycols; Predictive Value of Tests; Prisoners; Recombinant Proteins; Residence Characteristics; Retrospective Studies; Ribavirin; Risk Assessment; Severity of Illness Index; Sex Factors; Substance Abuse, Intravenous; Treatment Outcome; Young Adult	2012
Is the end of chronic hepatitis C virus infection in sight? The Medical journal of Australia, 2012, Jun-04, Volume: 196, Issue:10 Topics: Antiviral Agents; Drug Users; Hepatitis C, Chronic; Humans; Interferon-alpha; Models, Biological; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2012
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia. The Medical journal of Australia, 2012, Jun-04, Volume: 196, Issue:10 Topics: Antiviral Agents; Drug Therapy, Combination; Drug Users; Hepatitis C, Chronic; Humans; Interferon-alpha; Models, Biological; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Victoria	2012
Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:4 Topics: Adult; Antiviral Agents; Australia; Cohort Studies; Cost-Benefit Analysis; Drug Therapy, Combination; Early Medical Intervention; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Markov Chains; Models, Statistical; Polyethylene Glycols; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Victoria	2013
Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections. Medicine and health, Rhode Island, 2002, Volume: 85, Issue:11 Topics: Antiviral Agents; Blood-Borne Pathogens; Case Management; Hepatitis C; Humans; Interferons; Prisons; Rhode Island; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2002
Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes? Journal of acquired immune deficiency syndromes (1999), 2003, Apr-01, Volume: 32, Issue:4 Topics: Antiviral Agents; Disease Progression; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; HIV Seropositivity; Humans; Interferons; Liver Failure; Liver Function Tests; Ribavirin; Risk-Taking; Substance Abuse, Intravenous; Treatment Failure	2003
[Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 1 Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Jaundice; Male; Middle Aged; Needlestick Injuries; Pain; Punctures; Recombinant Proteins; Retrospective Studies; Ribavirin; Serotyping; Sexual Behavior; Substance Abuse, Intravenous; Tattooing; Time Factors; Treatment Outcome	2003
Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 29, Issue:3 Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance Abuse, Intravenous; Treatment Outcome	2004
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. Journal of medical virology, 2004, Volume: 73, Issue:3 Topics: Adolescent; Adult; Female; Genotype; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferons; Male; Prisoners; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Risk Factors; RNA, Viral; Serotyping; Substance Abuse, Intravenous	2004
[Hepatitis C and HIV in Spanish prisons]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:2 Topics: Adult; Antiviral Agents; Comorbidity; Female; Hepatitis C, Chronic; HIV Infections; HIV Seroprevalence; Hospitalization; Hospitals, Public; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prisoners; Prisons; Recombinant Proteins; Ribavirin; Seroepidemiologic Studies; Spain; Substance Abuse, Intravenous	2005
Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2005, Volume: 25, Issue:3 Topics: Adult; Antiviral Agents; Bell Palsy; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Myelin Sheath; Recombinant Proteins; Ribavirin; Schwann Cells; Self Tolerance; Substance Abuse, Intravenous	2005
Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40 Suppl 5 Topics: Adult; Antiviral Agents; Delivery of Health Care, Integrated; Eligibility Determination; Female; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Rhode Island; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2005
GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection. Journal of hepatology, 2005, Volume: 43, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepatitis C; Heterotrimeric GTP-Binding Proteins; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Protein Subunits; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Viral Load	2005
Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006, Volume: 38, Issue:2 Topics: Adult; Antiviral Agents; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2006
[Prevalence of hepatitis C virus among HIV-infected patients in Area 2 of Madrid]. Anales de medicina interna (Madrid, Spain : 1984), 2006, Volume: 23, Issue:3 Topics: Adult; Alcohol Drinking; Antiviral Agents; CD4 Lymphocyte Count; Comorbidity; Cross-Sectional Studies; Drug Utilization; Female; Hepatitis C; HIV Infections; Humans; Interferons; Male; Middle Aged; Outpatients; Prevalence; Ribavirin; Risk Factors; Seroepidemiologic Studies; Sexual Behavior; Spain; Substance Abuse, Intravenous; Surveys and Questionnaires; Urban Population; Viral Load	2006
Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin. The American journal of psychiatry, 2006, Volume: 163, Issue:8 Topics: Antiviral Agents; Behavior, Addictive; Cocaine-Related Disorders; Comorbidity; Drug Administration Schedule; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferons; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Care Planning; Recurrence; Ribavirin; Risk Assessment; Substance Abuse, Intravenous; Treatment Outcome	2006
Referral for chronic hepatitis C treatment from a drug dependency treatment setting. Drug and alcohol dependence, 2007, Apr-17, Volume: 88, Issue:1 Topics: Analgesics, Opioid; Antiviral Agents; Australia; Hepatitis C, Chronic; Humans; Interferon-alpha; Methadone; Referral and Consultation; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous	2007
[Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting]. Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:9 Topics: Anti-HIV Agents; Antiviral Agents; Biopsy; Comorbidity; Disease Progression; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Function Tests; Patient Compliance; Polyethylene Glycols; Practice Guidelines as Topic; Prevalence; Prisoners; Prisons; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Spain; Substance Abuse, Intravenous; Treatment Outcome	2006
[Treatment of chronic hepatitis C within a heroine-assisted treatment program]. Deutsche medizinische Wochenschrift (1946), 2006, Dec-15, Volume: 131, Issue:50 Topics: Administration, Oral; Adult; Antiviral Agents; Buprenorphine; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Hepatitis C, Chronic; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Rehabilitation, Vocational; Ribavirin; Social Adjustment; Social Welfare; Substance Abuse, Intravenous	2006
Enhancing hepatitis C treatment uptake and outcomes for injection drug users. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:1 Topics: Antiviral Agents; Hepatitis C; Humans; Interferons; Naltrexone; Narcotic Antagonists; Patient Compliance; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2007
Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study. World journal of gastroenterology, 2007, Jan-28, Volume: 13, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Interferon-alpha; Male; Middle Aged; Pilot Projects; Quality of Life; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous	2007
Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes. Addiction (Abingdon, England), 2007, Volume: 102, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome	2007
[Acute hepatitis C infection: epidemiological and clinical aspects, and efficacy of interferon therapy]. Le infezioni in medicina, 2007, Volume: 15, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antiviral Agents; Colonoscopy; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Sexual Behavior; Substance Abuse, Intravenous	2007
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. The International journal on drug policy, 2007, Volume: 18, Issue:5 Topics: Adult; Antiviral Agents; British Columbia; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Models, Organizational; Patient Acceptance of Health Care; Patient Care Team; Patient Education as Topic; Peer Group; Polyethylene Glycols; Program Evaluation; Recombinant Proteins; Referral and Consultation; Ribavirin; Self-Help Groups; Substance Abuse, Intravenous; Time Factors; Treatment Outcome	2007
Oral lesions in HIV and HCV co-infected individuals in HAART era. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2008, Volume: 37, Issue:8 Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Coitus; Disease Susceptibility; Feeding Behavior; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Mouth Diseases; Mouthwashes; Ribavirin; Risk Factors; Smoking; Substance Abuse, Intravenous; Time Factors; Viral Load; Young Adult	2008
[Hepatitis C in Scandinavia]. Nordisk medicin, 1995, Volume: 110, Issue:2 Topics: Carrier State; Hemophilia A; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Risk Factors; Scandinavian and Nordic Countries; Substance Abuse, Intravenous	1995
Managing chronic hepatitis C acquired through intravenous drug use. QJM : monthly journal of the Association of Physicians, 2001, Volume: 94, Issue:3 Topics: Adolescent; Adult; Antiviral Agents; Disease Progression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Male; Middle Aged; Patient Acceptance of Health Care; Patient Compliance; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Severity of Illness Index; Substance Abuse, Intravenous; Treatment Outcome	2001
Treatment of hepatitis C infection in injection drug users. Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:1 Topics: Adult; Alanine Transaminase; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Opioid-Related Disorders; Patient Compliance; Polymerase Chain Reaction; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Sex Characteristics; Substance Abuse, Intravenous; Treatment Outcome	2001
Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug and alcohol dependence, 2002, Jul-01, Volume: 67, Issue:2 Topics: Adult; Aged; Chi-Square Distribution; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferons; Male; Methadone; Middle Aged; Ribavirin; Substance Abuse, Intravenous	2002